Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Conference Correspondent
Bendamustine-Rituximab versus Rituximab Monotherapy for Older Patients with Nodal or Splenic Marginal Zone Lymphoma
ASH 2019 Wrap-up
,
ASH Highlights
Conference Correspondent
— January 16, 2020
A large observational study showed increased first-line bendamustine-rituximab use among older patients with splenic or nodal marginal zone lymphoma was not associated with significant event-free survival or overall survival benefit versus single-agent rituximab, but led to increased toxicities and costs.
Read Article
Acalabrutinib Monotherapy in Patients with Relapsed/Refractory CLL: 42-Month Follow-Up of a Phase 2 Study
ASH 2019 Wrap-up
,
ASH Highlights
Conference Correspondent
— January 16, 2020
Updated results from a phase 1/2 trial indicate that acalabrutinib monotherapy was associated with a favorable safety profile and showed antileukemic activity in patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma, irrespective of high-risk genomic features.
Read Article
Pharmacy’s Emerging Influence and the Roles Pharmacists Play
AVBCC 2019 Summit
Conference Correspondent
— October 25, 2019
Leaders in oncology pharmacy tackle some of the biggest issues in the field today in a pre-summit professional development session.
Read Article
Cancer Centers and the Integrated Health Delivery Systems and the Cancer Care Value Perspectives
AVBCC 2019 Summit
Conference Correspondent
— October 25, 2019
Stakeholders address the challenge of integrating high-cost therapies into cancer care delivery.
Read Article
Insurance Payers and the Cancer Care Value Perspectives
AVBCC 2019 Summit
Conference Correspondent
— October 25, 2019
Payers identify strategies for promoting value-based, high-quality cancer care.
Read Article
Keynotes Highlight a Successful Summit—Stellar Duo Delivers Outstanding Talks
AVBCC 2019 Summit
Conference Correspondent
— October 25, 2019
A pair of distinguished keynote speakers gave attendees a rare behind-the-scenes look at healthcare policy decisions at the highest levels.
Read Article
Working with Integrated Health Delivery Systems in Cancer Care Ecosystem
AVBCC 2019 Summit
Conference Correspondent
— October 25, 2019
The Summit kicked off with opening remarks and the first of the event’s in-depth pre-summit professional development sessions—designed to take a deep dive into select topics.
Read Article
Efforts to Maximize Value-Based Cancer Care in a Fragmented Care Delivery System
AVBCC 2018 Summit
Conference Correspondent
— December 24, 2018
Despite the fragmented nature of the U.S. care delivery and payment system, disparate healthcare stakeholders continue to seek areas of alignment in reducing inefficiencies and enhancing value-driven oncology care.
Read Article
Quantifying the Impact and Value of Oncology Navigation on Patient Outcomes
AVBCC 2018 Summit
Conference Correspondent
— December 24, 2018
The development and implementation of validated, evidence-based oncology navigation measures are an integral component of broader efforts to promote patient-centric, value-based cancer care.
Read Article
Value-Based Payment Reform: Focus on the Oncology Care Model
AVBCC 2018 Summit
Conference Correspondent
— December 24, 2018
The Oncology Care Model was designed to provide higher quality, more highly coordinated oncology care at the same or lower cost to Medicare. As the program matures, new data is expected to provide insight on the achievement of that ambitious goal.
Read Article
Page 11 of 44
6
7
8
9
10
11
12
13
14
15
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma